Publications

Journal Article
Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Ppublish 171 citations
Electronic publication date
June 26, 2008

View on Pubmed.gov 18511069 | View on doi.org 10.1016/j.jmb.2...

Engineered bacterial outer membrane vesicles with enhanced functionality.

Search for publications in this journal J Mol Biol - 380(1):51-66

Abstract

We have engineered bacterial outer membrane vesicles (OMVs) with dramatically enhanced functionality by fusing several heterologous proteins to the vesicle-associated toxin ClyA of Escherichia coli. Similar to native unfused ClyA, chimeric ClyA fusion proteins were found localized in bacterial OMVs and retained activity of the fusion partners, demonstrating for the first time that ClyA can be used to co-localize fully functional heterologous proteins directly in bacterial OMVs. For instance, fusions of ClyA to the enzymes beta-lactamase and organophosphorus hydrolase resulted in synthetic OMVs that were capable of hydrolyzing beta-lactam antibiotics and paraoxon, respectively. Similarly, expression of an anti-digoxin single-chain Fv antibody fragment fused to the C terminus of ClyA resulted in designer "immuno-MVs" that could bind tightly and specifically to the antibody's cognate antigen. Finally, OMVs displaying green fluorescent protein fused to the C terminus of ClyA were highly fluorescent and, as a result of this new functionality, could be easily tracked during vesicle interaction with human epithelial cells. We expect that the relative plasticity exhibited by ClyA as a fusion partner should prove useful for: (i) further mechanistic studies to identify the vesiculation machinery that regulates OMV secretion and to map the intracellular routing of ClyA-containing OMVs during invasion of host cells; and (ii) biotechnology applications such as surface display of proteins and delivery of biologics.

References

Appl Environ Microbiol. 2002 Apr;68(4):2026-30

J Bacteriol. 1995 Jul;177(14):3998-4008

J Biol Chem. 2002 Dec 27;277(52):51077-83

J Bacteriol. 2003 Sep;185(18):5491-9

Cited by 171 citations (total)

Journal Article Research Support, N.I.H., Extramural

A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans.

Electronic publication date July 23, 2011

Search for publications in this journal Infect Immun

Manli Qi [...] Guangming Zhong et al.

The Chlamydia trachomatis outer membrane complex protein B (OmcB) is an antigen with diagnostic and vaccine relevance. To further characterize...

Journal Article Research Support, Non-U.S. Gov't

Vaccinology: The art of putting together the right ingredients.

Electronic publication date October 27, 2017

Search for publications in this journal Hum Vaccin Immunother

Alberto Grandi [...] Guido Grandi et al.

Historically vaccines were produced using whole attenuated or killed pathogens and still a large proportion of current vaccines utilizes such...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances